(Q57603148)

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Familial and genetic susceptibility to major neonatal morbidities in preterm twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Prospective analysis of pulmonary hypertension in extremely low birth weight infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pathology of new bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pathology of bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Persistently elevated right ventricular index of myocardial performance in preterm infants with incipient bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, cardiovascular anomalies and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

From BPD to COPD? The hypothesis is intriguing but we lack lung pathology data in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Long-term efficacy of bosentan in treatment of pulmonary arterial hypertension in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Use of inhaled iloprost in an infant with bronchopulmonary dysplasia and pulmonary artery hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pulmonary hypertension in infants with bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

B-type natriuretic Peptide assay for the diagnosis and prognosis of patent ductus arteriosus in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pulmonary vascular effects of inhaled nitric oxide and oxygen tension in bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Sildenafil citrate, bronchopulmonary dysplasia and disordered pulmonary gas exchange: any benefits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Nebulized iloprost and noninvasive respiratory support for impending hypoxaemic respiratory failure in formerly preterm infants: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Effects of long-term bosentan in children with pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Right heart pressure determination by Doppler in infants with tricuspid regurgitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Echocardiographic detection of pulmonary hypertension in extremely low birth weight infants with bronchopulmonary dysplasia requiring prolonged positive pressure ventilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Health-care utilization and respiratory morbidities in preterm infants with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

The utility of sildenafil in pulmonary hypertension: a focus on bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241

Epoprostenol and home mechanical ventilation for pulmonary hypertension associated with chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBDRA.23241